Solomon Tesfaye

Active 1992–2025

122
Papers
19,835
Citations
76
h-index
111
i10-index

Citations

Citations per year for Solomon Tesfaye1992: 1 citations1993: 4 citations1994: 7 citations1995: 13 citations1996: 21 citations1997: 6 citations1998: 21 citations1999: 11 citations2000: 13 citations2001: 25 citations2002: 19 citations2003: 40 citations2004: 51 citations2005: 74 citations2006: 69 citations2007: 69 citations2008: 76 citations2009: 82 citations2010: 59 citations2011: 131 citations2012: 135 citations2013: 162 citations2014: 184 citations2015: 149 citations2016: 127 citations2017: 138 citations2018: 181 citations2019: 588 citations2020: 675 citations2021: 704 citations2022: 551 citations2023: 407 citations2024: 723 citations2025: 321 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,044 citing papers, 16.5% of this breakdownUnited Kingdom: 704 citing papers, 11.1% of this breakdownChina: 512 citing papers, 8.1% of this breakdownGermany: 302 citing papers, 4.8% of this breakdownItaly: 261 citing papers, 4.1% of this breakdownAustralia: 202 citing papers, 3.2% of this breakdownCanada: 185 citing papers, 2.9% of this breakdownIndia: 185 citing papers, 2.9% of this breakdownDenmark: 180 citing papers, 2.8% of this breakdownFrance: 144 citing papers, 2.3% of this breakdownNetherlands: 142 citing papers, 2.2% of this breakdownJapan: 126 citing papers, 2% of this breakdown
0%16.5%Other 37.1%

Fields

  • Medicine80.9%
  • Biochemistry, Genetics and Molecular Biology9%
  • Neuroscience3.9%
  • Health Professions1.4%
  • Agricultural and Biological Sciences0.8%
  • Engineering0.6%
  • Other3.4%

Topics

  • Pain Mechanisms and Treatments13.6%
  • Diabetic Foot Ulcer Assessment and Management4.8%
  • Botulinum Toxin and Related Neurological Disorders4.3%
  • Heart Rate Variability and Autonomic Control2.8%
  • Diabetes Management and Research2.2%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2.1%
  • Other70.2%

Coauthors

All papers

Open in search
  1. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

    Authors: , , , , , , , , , , , , - Diabetes Care 2010 cited by 2,635

  2. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy

    Authors: , , - Nature Reviews Endocrinology 2021 cited by 500

  3. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention

    Authors: , , , , , , - The Lancet Diabetes & Endocrinology 2019 cited by 531

  4. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Bennett, Dinesh Selvarajah - The Lancet 2022 cited by 191

  5. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management

    Authors: , , , , , , , , , , , , - Diabetes/Metabolism Research and Reviews 2011 cited by 954

  6. Vascular Risk Factors and Diabetic Neuropathy

    Authors: , , , , , , , - New England Journal of Medicine 2005 cited by 1,281

  7. Diabetes in sub-Saharan Africa: from clinical care to health policy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip I. Burgess, Matthew J. Burton, Jeanne Chai, Felix P. Chilunga, Portia Chipendo, Anna Conn, Dipesalema Joel, Arielle Wilder Eagan, Crispin Gishoma, Julius Ho, Simcha Jong, Sujay Kakarmath, Yasmin Khan, Ramu Kharel, Michael Anne Kyle, Seitetz C. Lee, Amos Lichtman, Carl Philip Ocquaye Malm, Maïmouna Ndour Mbaye, Marie Aimée Muhimpundu, Beatrice Mwagomba, Kibachio Joseph Mwangi, Mohit Nair, Simon Pierre Niyonsenga, Benson Njuguna, Obiageli Okafor, Oluwakemi Okunade, Paul H. Park, Sonak D. Pastakia, Chelsea Pekny, Ahmed Reja, Charles Rotimi, Samuel Rwunganira, David Sando, Gabriela Sarriera, Anshuman Sharma, A.T. Sidibé, Elias S. Siraj, Azhra S Syed, Kristien Van Acker, Mahmoud Werfalli - The Lancet Diabetes & Endocrinology 2017 cited by 545

  8. The Pain in Neuropathy Study (PiNS)

    Authors: , , , , , , , , - Pain 2016 cited by 307

  9. A new look at painful diabetic neuropathy

    Authors: , , , , , , , - Diabetes Research and Clinical Practice 2018 cited by 196

  10. Painful and Painless Diabetic Neuropathies: What Is the Difference?

    Authors: , , , , , , , , - Current Diabetes Reports 2019 cited by 174

  11. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations.

    Authors: , , , , , , , , , , , , , , - Diabetes Research and Clinical Practice 2021 cited by 188

  12. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy

    Authors: , - Diabetes/Metabolism Research and Reviews 2012 cited by 608

  13. Duloxetine and pregabalin: High-dose monotherapy or their combination? The “COMBO-DN study” – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain

    Authors: , , , , , , , , - Pain 2013 cited by 304

  14. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy

    Authors: , , , - Diabetologia 2001 cited by 697

  15. Mechanisms and Management of Diabetic Painful Distal Symmetrical Polyneuropathy

    Authors: , , - Diabetes Care 2013 cited by 350

  16. New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine

    Authors: , , , , , , - Frontiers in Endocrinology 2020 cited by 149

  17. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study

    Authors: , , , , , , , , - Diabetologia 1996 cited by 704

  18. Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Pain 2017 cited by 201

  19. Female sex is a risk factor for painful diabetic peripheral neuropathy: the EURODIAB prospective diabetes complications study

    Authors: , , , , , , , , , , - Diabetologia 2023 cited by 47

  20. Reversing painful and non-painful diabetic neuropathy with the capsaicin 8% patch: Clinical evidence for pain relief and restoration of function via nerve fiber regeneration

    Authors: , , , , , , - Frontiers in Neurology 2022 cited by 47

  21. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy

    Authors: , , , , , , , , , , - Diabetologia 2005 cited by 328

  22. Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial

    Authors: , , , , , , , - Nutrients 2021 cited by 153

  23. Structural and Functional Abnormalities of the Primary Somatosensory Cortex in Diabetic Peripheral Neuropathy: A Multimodal MRI Study

    Authors: , , , , , , , , , , - Diabetes 2019 cited by 109

  24. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management

    Authors: , , , , , , , , - Diabetes/Metabolism Research and Reviews 2011 cited by 407